GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Starry Pharmaceutical Co Ltd (SHSE:603520) » Definitions » Total Long-Term Liabilities

Zhejiang Starry Pharmaceutical Co (SHSE:603520) Total Long-Term Liabilities : ¥811 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Zhejiang Starry Pharmaceutical Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Zhejiang Starry Pharmaceutical Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥811 Mil.

Zhejiang Starry Pharmaceutical Co Total Long-Term Liabilities Historical Data

The historical data trend for Zhejiang Starry Pharmaceutical Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Starry Pharmaceutical Co Total Long-Term Liabilities Chart

Zhejiang Starry Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,017.45 794.78 771.18 826.13 733.80

Zhejiang Starry Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 885.34 630.84 616.21 733.80 811.32

Zhejiang Starry Pharmaceutical Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Zhejiang Starry Pharmaceutical Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Zhejiang Starry Pharmaceutical Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Starry Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Starry Pharmaceutical Co Ltd (SHSE:603520) » Definitions » Total Long-Term Liabilities
Comparable Companies
SHSE:688799 BJSE:832735 SHSE:600351 SZSE:002393 SHSE:600488 SHSE:688247 SHSE:600479 SZSE:300485 SHSE:600829 SZSE:002728 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No.1 Sitali Avenue, Modern Industrial Gathering District, Zhejiang Province, Xianju County, Taizhou City, CHN, 317306
Website
http://www.starrypharm.com
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Executives
Hu Jin Sheng Director

Zhejiang Starry Pharmaceutical Co Headlines

No Headlines